Production (Stage)
Oncolytics Biotech Inc.
ONCY
$0.36
$0.02728.17%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -26.79% | 21.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.09% | -16.96% | |||
| Operating Income | 19.09% | 16.96% | |||
| Income Before Tax | 18.41% | 18.28% | |||
| Income Tax Expenses | -- | 86.36% | |||
| Earnings from Continuing Operations | 18.64% | 18.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 18.64% | 18.15% | |||
| EBIT | 19.09% | 16.96% | |||
| EBITDA | 19.29% | 16.75% | |||
| EPS Basic | 25.34% | 18.72% | |||
| Normalized Basic EPS | 25.22% | 18.87% | |||
| EPS Diluted | 25.34% | 18.72% | |||
| Normalized Diluted EPS | 25.22% | 18.87% | |||
| Average Basic Shares Outstanding | 9.10% | 0.72% | |||
| Average Diluted Shares Outstanding | 9.10% | 0.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||